Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)

Reflecting On Patient Monitoring Stocks’ Q3 Earnings: ResMed (NYSE:RMD)

RMD : 257.58 (-1.20%)
ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?

ResMed (RMD): Buy, Sell, or Hold Post Q3 Earnings?

RMD : 257.58 (-1.20%)
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday,...

RMD.AX : 38.040 (-0.94%)
RMD : 257.58 (-1.20%)
What You Need to Know Ahead of ResMed's Earnings Release

ResMed will release its second-quarter earnings soon, and analysts anticipate a low double-digit bottom-line growth.

XLV : 155.74 (-0.78%)
$SPX : 6,940.01 (-0.06%)
RMD : 257.58 (-1.20%)
1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

1 Cash-Heavy Stock to Consider Right Now and 2 We Avoid

RMD : 257.58 (-1.20%)
WDAY : 186.86 (-3.04%)
SAM : 206.81 (-4.29%)
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

WDFC : 204.99 (-0.40%)
RMD : 257.58 (-1.20%)
CR : 207.42 (+0.25%)
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present...

RMD.AX : 38.040 (-0.94%)
RMD : 257.58 (-1.20%)
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

INSP : 92.23 (-4.40%)
RMD : 257.58 (-1.20%)
SGRY : 15.90 (-0.63%)
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received...

RMD.AX : 38.040 (-0.94%)
RMD : 257.58 (-1.20%)
Is ResMed Stock Underperforming the S&P 500?

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,940.01 (-0.06%)
RMD : 257.58 (-1.20%)
ISRG : 535.00 (-1.17%)

Barchart Exclusives

The 3 Most Reliable Dividend Stocks to Buy for Years to Come
These three dividend stocks are long-term winners with dependable payouts. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar